Latest News

A selection of recent news and views from Catapult Ventures follows...

Panthera further strengthens its oncology clinical trials team with the appointment of Matt Cooper as General Manager Oncology

Panthera Biopartners, an independent SMO (Site Management Organisation), has appointed Matt Cooper as General Manager, Oncology. Matt has extensive experience in the recruitment and running of clinical trials in oncology. Until recently, Matt has...

Biorelate signs multi-year deal with e-therapeutics

Biorelate has announced a new 3 year contract with e-therapeutics PLC for Galactic Data. After 2 successful years of collaboration, Biorelate will continue to provide auto-curated cause-and-effect data to fuel e-therapeutics’ data...

Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease

Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from homeTest can guide lifestyle interventions to potentially slow disease progre...

The pill could be sold in pharmacies without prescription

Some contraceptive pills could be sold over the counter in the UK for the first time, the government has said. It is asking the public for their views on whether two progestogen-only pills, also known as the "mini-pill", should be available witho...

Maxwellia spearheading shift to self-care with three pharmacy products in launch pipeline

Push to convert more prescription medicines to over-the-counter will put pharmacists at heart of nation's public health, helping futureproof NHS LONDON, Feb. 11, 2021 - Pioneering pharma company Maxwellia is poised to transform the UK's...

From our portfolio



Ergomed is developing first-in-class clotting agents for the treatment of bleeding or 'haemostasi...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200